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Abstract 
Purpose: To quantify the deformations of the femoropopliteal (FP) segment in 
patients undergoing endovascular revascularization and to compare the post-
treatment deformations caused by primary nitinol stent implantation to those 
produced by percutaneous transluminal angioplasty (PTA).   
Methods: Thirty-five patients (mean age 69±10 years; 20 men) scheduled for 
endovascular therapy were recruited for the study. During endovascular 
interventions, angiographic images were acquired with the legs stra ight and with 
a hip/knee flexion of 20°/70°. Image acquisition was performed before PTA for 
all patients, after PTA in 17 patients receiving this treatment only, and after 
primary stent implantation in the remaining 18 patients. A semi-automatic 
approach was used to reconstruct the 3-dimensional patient-specific artery 
models from 2-dimensional radiographs. Axial shortening and curvature changes 
in the arteries in vivo were calculated for the calcified, dilated, and stented 
regions, as well as the regions that were distal and proximal to the diseased and 
treated segments.  
Results: Leg flexion resulted in shortening of the artery in all investigated FP 
segments. The dilated arteries exhibited greater shortening compared to their 
stented counterparts (post-PTA 7.6%±4.9%, post-stent 3.2%±2.9%; p=0.004). 
Leg flexion also led to an increase in the curvatures of all the sections of the FP 
segment. While stented arteries had significantly higher curvature values than 
PTA within the regions proximal to the treated sections, the choice of the 
treatment method did not affect the curvature of the other segments. Despite 
this, 40% of the stented arteries exhibited kinking during leg flexion.   
Conclusion: The choice of the treatment method affects the post-interventional 
axial deformations of the FP segment but does not influence the curvature 
behavior. While PTA results in a more flexible artery, stents restrict the arteries’ 
shortening capabilities. Depending on the anatomical position of the stents, this 
axial stiffening of the arteries may lead to chronic kinking, which may cause 
occlusions and, consequently, impact the long-term success of the procedure. 
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Introduction 
For over a decade, endovascular therapy has been the primary treatment 
method for most patients with peripheral artery disease (PAD).1 The main 
challenge with this treatment has been to overcome comparatively high 
restenosis rates in the femoropopliteal (FP) segment and the need for target 
lesion revascularization (TLR). The implantation of nitinol stents following 
percutaneous transluminal angioplasty (PTA) using conventional uncoated 
balloons improved restenosis rates2–5 but led to a new set of problems, such as 
arterial wall damage through stent-artery interactions,6–8 loss of primary patency 
due to neointimal hyperplasia or stent fractures,9–11 or restriction of the natural 
deformation behavior of the FP tract.12,13 The invention of drug-eluting nitinol 
stents, along with improved stent designs, partially solved these issues.14–16 The 
remaining occurrences of restenosis are hypothesized to have a mechanical 
origin and to be caused by the stent ’s effects on arterial deformation during leg 
flexion.12,13  
 With the advent of drug-coated balloons, bioresorbable stents, and 
atherectomy devices, the state of the art in the endovascular treatment of FP 
lesions is moving away from stent placement and toward the so-called "leave 
nothing behind" strategy.17,18 The motivation behind this approach is to 
completely resolve the problems caused by the presence of permanent metal 
scaffolds. A limited number of nonrandomized clinical t rials addressed the 
efficacy of this technology, and initial results showed superior outcomes vs both 
balloon angioplasty and uncoated stents, as well as similar primary patency and 
TLR rates compared with drug-coated stents.16,18,19 However, contradictory 
outcomes among different devices suggest that the technology needs further 
advancements before it can be considered the gold standard among the 
available endovascular treatments.16,19,20 Furthermore, stent placement will 
continue to be utilized for cases in which PTA fails to provide optimal 
revascularization. Therefore, there is a need to improve the long-term outcomes 
of stent implantation in the FP segment. To reduce the risk of restenosis, current 
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stent designs should be adapted to conform to the dynamic mechanical 
environment in the FP segment. 
 In order to observe whether PTA provides better arterial flexibility 
compared to stent placement, axial deformation and bending behavior of the FP 
segment following both approaches need to be investigated. While several 
publications reported the in vivo deformations of healthy and calcified arteries in 
both living subjects and cadavers,21–27 only 2 studies examined the arterial 
deformations of patients who underwent stent placement.28,29 However, both 
studies had limitations that impacted the significance and interpretation of their 
results. The study from Nikanorov et al28 considered only a single nitinol stent, 
and the measurements were performed on single 2-dimensional (2D) 
radiographs, overlooking the 3-dimensional (3D) nature of the vessel 
deformations. On the other hand, Ganguly et al29 mainly focused on the 
methodology and validation behind the deformation analyses and provided 
limited information concerning the flexion angle, stent types, and lesion 
locations, thereby making it difficult to interpret their findings. Additionally, the 
implications of conventional balloon angioplasty on the deformation behavior of 
the FP segment are currently not known. Therefore, the objective of this work 
was to quantify the in vivo FP segment deformations of patients undergoing 
primary nitinol stent implantation compared with PTA alone. In addition, by 
comparing the post-PTA deformation behavior with the deformations following 
stent implantation, recommendations could be made to improve existing stent 
designs to overcome current shortcomings. 
 
Methods 
Study Design and Data Acquisition 
Thirty-five patients (mean age 69±10 years; 20 men) scheduled for endovascular 
therapy were recruited to undergo 2D radiographic imaging of their lower  limbs. 
All patients were classified with Fontaine stage IIb ischemia and had a mean 
lesion length of 69±9 mm. Information about lesion locations, as well as the 
calcification levels, are presented in Table 1. This study was approved by the 
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local ethics committee, and each patient signed a consent form for inclusion in 
the study and use of anonymized data outside the clinical environment.  
 The method of treatment for each patient was decided during 
endovascular therapy. All patients underwent initial PTA, in which the balloon 
was expanded to ~10 atmospheres. Based on a qualitative evaluation of lesion 
behavior and artery recoil, primary stent implantation was deemed necessary for 
18 patients. Three patients received 2 stents for a total of 21 self-expanding 
nitinol stents (Table 1): 6 Pulsar 18 (Biotronik AG, Bülach, Switzerland); 1 Xpert 
(Abbott Vascular, Santa Clara, CA, USA); 5 Zilver PTX (Cook Medical Inc., 
Bloomington, IN, USA); and 9 Protégé EverFlex (Medtronic/Covidien, Mansfield, 
MA, USA). Stents were sized to overlap ~5 mm into the healthy proximal and 
distal segments surrounding the lesions. Among the remaining 17 patients who 
underwent solely PTA, only 2 patients were treated with drug-coated balloons, 
and all were subjected to subsequent balloon expansion until an adequate 
lumen diameter was reached. Patients were followed with oscillometry, ankle-
brachial index measurement, and duplex sonography at 3, 6, and 12 months 
following the endovascular procedure. 
 All angiographic images were acquired with a Philips Allura FD 20 Xper X-
ray system with Clarity Upgrade (Philips Medical Systems, Best, the Netherlands). 
Contrast material was diluted by 50% with saline and injected via the sheath. 
Prior to the acquisitions, a lightweight calibration phantom was attached to the 
patient’s thighs using a strap. The initial acquisition was performed first with the 
leg straight and then with a hip/knee flexion of 20°/70° both before and after 
treatment. At each configuration, a set of 2 images was acquired, separated by 
an average view angle of 45° to 60°. The images were stored on the workstation 
as subtraction angiography and cine images.  
 
3D Reconstruction of the Vessel Centerline 
The calibration phantom was required to reconstruct the 3D centerline of the 
arteries from 2D images. The phantom consisted of 16 radiopaque spherical 
fiducials that were projected onto the angiographic images as black circular 
JEVT_16-0217_Gökgöl_Accepted.doc – page 7 
spots. The particular 2D fiducial positions, together with a priori 3D information 
on the fiducial locations, were used to calibrate each angiographic image.30 The 
resulting calibration parameters provided accurate information on the spatial 
relationship of the acquired images. Based on this spatial relationship, 
corresponding 2D image locations could be triangulated to a unique 3D position. 
This triangulation concept was used to retrieve the 3D information of the 
centerline.31  
 The vessel boundary was defined by picking 2D image points along its 
projected outline. After defining the artery boundary in 1 image, the beginning 
and the end of the vessel were represented on the second view in terms of 2 
epipolar lines, which were used as a guide to outline the boundary of the vessel 
in the respective other view. The defined boundary points were further 
interpolated, and pairs of opposing boundary points were used to compute 
respective center points. The set of 2D center points from both views were then 
triangulated to retrieve the centerline in 3D. A validation involving the mean 
forward and backward projection errors conf irmed the accuracy of the 
reconstruction methodology.31 
 In order to identify the corresponding vessel locations on the straight and 
flexed knee images, certain landmarks were placed at the stent/balloon ends 
and at corresponding side branches between each image using the epipolar 
constraint. Furthermore, to make sure that the same vessel regions were being 
considered between pre- and post-treatment images, the landmarks at the 
stent/balloon ends were projected onto the pre-PTA images to accurately 
identify the lesion ends. All the landmarks were extracted as 3D points.  
 
Artery Deformations 
A previously established methodology was adopted to estimate vessel 
deformations.32 The calculations were directly performed on the reconstructed 
centerlines, which were each divided into 3 sections defined by the landmarks 
that were used to identify the corresponding locations on the straight and flexed 
images (ie, proximal to lesion, lesion center, and distal to lesion for the 
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pretreatment measurements and proximal to treated region, stented/dilated 
region, and distal to treated region for post-treatment measurements). The 
sample sizes for each section of the FP segment are reported in Table 2. 
 The deformations investigated in this study were the changes in length 
and curvature due to flexion of the leg. The lengths of the individual vessel 
sections were estimated by calculating the total linear distance between the 
landmarks defining the boundaries of each section. As such, the axial 
deformation was defined as the change in length between flexed and straight 
positions divided by the undeformed length in the straight position.  
 The curvature at a single location was measured by fitting a circle to 3 
consecutive points on the centerline.32 The distance between each consecutive 
point corresponded to the average vessel diameter and was updated with 
respect to the investigated FP region. The curvature was defined as the inverse 
of the radius of the circle. Moving this circle along the entire centerline provided 
the complete curvature profile of a vessel section. Both the mean and maximal 
curvature changes were then calculated as the difference between the curvature 
profiles in the straight and flexed positions.  
 
Statistical Analysis 
Statistical significance regarding the effects of leg flexion, as well as the 
influences of stent implantation and PTA on deformations, was assessed using 
paired t tests. The threshold of statistical significance was p<0.05. Based on the 
follow-up data, the rate of symptomatic restenosis within 6 months of the 
procedure was calculated. Additionally, associations between restenosis and 
nonphysiological FP deformations including kinking were explored using logistic 
regression analyses. The outcomes are reported as the odds ratio and risk ratio, 
respectively, with the 95% confidence interval. Statistical analyses were 
performed using Matlab (version 7.13; The Mathworks Inc., Natick, MA, USA).  
 
 
Results 
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Prior to endovascular treatment, the vessel sections of all samples shortened 
with leg flexion (Table 2). Within the lesion, the average shortening was higher 
for the stent group (–6.4%±3.4%) than the PTA group (–4.6%±3.0%). However, 
this difference was not statistically significant (p=0.11). Furthermore, it was not 
possible to make a relevant comparison in the proximal regions as there was 
data from only 1 patient for the pre-stent proximal group. 
 Regardless of the treatment method, the shortening behavior was 
preserved for all sections after the operation. For the patients treated with PTA 
only, the average shortening within the treated regions (–7.6%±4.9%) increased 
compared to the diseased regions (5.0%±2.3%). On the other hand, patients 
who received stents showed a statistically significant decrease in the average 
shortening within the stented regions as opposed to their pretreatment 
counterparts (post-stent –3.2%±2.9% vs pre-stent –6.4%±3.4%, p=0.005). 
Consequently, a statistically significant increase in the axial flexibility of the 
treated artery section was observed when the treatment did not involve primary 
stent implantation (post-PTA vs post-stent p=0.004).  
 The mean and maximal curvatures of all the vessel sections increased 
with leg flexion. For both the diseased and treated regions, the average 
curvature values nearly doubled with flexion (Table 2). Prior to the treatment, 
there were no statistically significant differences between the curvature 
behaviors of the stent and PTA groups, either within the lesion or distal to the 
lesion. Likewise, the average curvature values in these regions were similar 
before and after treatment (Table 2). However, similar statements for the 
proximal regions could not be made due to limited data in the pre-stent proximal 
group.  
 Within the regions proximal to the treated segments, the mean and 
maximum curvature values in the flexed positions were significantly higher with 
stented arteries than when only PTA was performed (mean curvature p=0.008; 
maximum curvature p=0.02). For the remaining vessel sections, the average 
curvature values did not show any significant differences between different 
treatment methods. Despite this, stent implantation resulted in notable kinking in 
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7 patients (Figure 1). The kinking almost always occurred within 1 cm of the 
distal stent end when the stents were implanted toward the popliteal artery. The 
only exception was 1 patient who had the stent implanted along the full length of 
the popliteal artery, which caused the kinking to occur in the distal superficial 
femoral artery (SFA), 1 cm from the proximal end of the stent. There was no 
visible evidence of kinking in the arteries treated with PTA. 
 With regard to the different anatomical sections along the FP segment, the 
average maximal curvature change in the popliteal artery (pre-PTA 0.32±0.18 
cm-1, post-PTA 0.29±0.13 cm-1, post-stent 0.34±0.16 cm-1) was always 
significantly higher than both the distal SFA (pre-PTA 0.11±0.08 cm-1, post- PTA 
0.07±0.02 cm-1, post-stent 0.16±0.16 cm-1) and mid SFA (pre-PTA 0.07±0.05 
cm-1, post-PTA 0.07±0.07 cm-1, post-stent 0.12±0.11 cm-1). No significant 
differences were found in the bending behaviors between the distal and mid SFA. 
Finally, there was no statistically significant difference in the deformations 
caused by the 3 different stent designs.  
 Clinically, 1 of the 35 patients died within 10 months of the procedure and 
was not available for a routine follow-up. Among the remaining patients, 7 
experienced FP reobstruction as documented by duplex ultrasound: 2 patients 
within 30 days and 5 patients within 6 months. Of note, 4 of these patients had 
exhibited kinking with leg flexion immediately after the treatment. According to 
the regression analyses, this distribution of data resulted in a risk ratio of 5.0 
(95% CI 1.48 to 17.86, p=0.01) and an odds ratio of 10.0 (95% CI 1.57 to 72.67, 
p=0.02), suggesting that the possibility of restenosis increases with the 
presence of kinking.  
 
Discussion 
The main drawback of endovascular therapy in the FP segment is the risk of 
restenosis.1,5 Recent clinical trials reported the long-term restenosis rates in that 
challenging FP segment to be 17% with drug-eluting stents15 and 20% with drug-
coated balloons.16 While these numbers are an improvement over the long-term 
outcomes obtained with uncoated devices,4,18 they also further underline the 
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hypothesis that the persisting restenosis rates can be attributed to the 
mechanical deformations of the FP segment.  
 The deformations in healthy SFA and popliteal arteries have been the 
subject of numerous studies.21,23–26 However, comparisons between these 
studies (ie, old vs young patients, living subjects vs cadavers) show that the 
deformations are heavily dependent on the composition of the arteries. 25,26 As 
such, these studies can present only limited information to improve current 
treatment methods and devices. To this end, it is crucial to analyze the 
deformations of arteries with PAD prior to and after endovascular treatment.  A 
recent study from Ní Ghriallais and colleagues27 was a first step toward 
achieving this goal as they reported FP deformation data pre/post stenting using 
cadaver limbs removed from patients with PAD. Studies such as this would not 
only provide information on the vessel deformations of the target population, but 
also on the mechanical state of the artery resulting from different treatment 
modalities. The aim of our study was to estimate the in vivo deformations of 35 
diseased FP segments prior to endovascular treatment and immediately after 
PTA or primary stent implantation. 
 For all FP segments, the lengths of the arteries shortened and their mean 
and maximum curvatures increased as the leg moved to a flexed position. This 
general deformation behavior was similar before and just after stent implantation 
and balloon angioplasty. Furthermore, both the axial deformation and curvature 
behaviors within the lesion showed no significant differences between the pre -
stent and pre-PTA groups, which suggests that the choice of the treatment 
method was not influenced by the deformations of the diseased arteries.  
 The treatment had a statistically significant effect on the axial deformation 
behaviors of the diseased segments due to leg flexion. Performing PTA resulted 
in increased axial shortening, while primary stent implantation led to decreased 
axial compressibility. On the other hand, both procedures had a limited impact 
on the axial deformations of the regions distal to the diseased sections. Similarly, 
PTA had no effect on the axial behavior of the artery in the proximal regions.  
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 Stented arteries had a significantly higher mean and maximum curvature 
values compared to the arteries that underwent only PTA in the regions proximal 
to the treated sections. However, there was only one 1 subject with data in the 
segment proximal to the lesion in the pre-stent group. As a result, it is not clear 
if the statistically significant differences observed between the mean and 
maximum curvatures of stented and dilated arteries were already present prior 
to the treatments or were caused by the different treatment methods. Within the 
treated and distal to the treated sections, the average bending behavior of the 
FP segment due to leg flexion was similar between the 2 treatment methods. 
However, 40% of the patients who received stents exhibited kinking either distal 
or proximal to the stent ends immediately after the procedure (Figure 1). In 
contrast, arteries that were treated with PTA only were not associated with 
kinking, and in 1 patient the procedure was even found to resolve an identified 
case of kinking observed before treatment, resulting in a smoother bending 
behavior (Figure 2). 
 Our results suggest that the restrictions imposed by the stents on the axial 
shortening capabilities of the arteries are liable to produce extreme deformations. 
Due to the FP segment’s posterior location to the knee joint, the overall length  of 
the FP segment is expected to decrease during flexion. If the vessel is not able 
to compress axially, the additional tissue would either form a curve of its own or 
join a pre-existing curve, resulting in an increased curvature profile and, 
possibly, kinking. This is especially true for the cases in which stent implantation 
occurs in the sections of the FP segment that undergo greater deformation with 
leg flexion, such as the distal SFA and the popliteal artery.23,28,29,31 The 
comparisons between the 2 treatment methods further support the relation 
between kinking and increased axial stiffness due to stent placement.  
 Previous clinical studies have suggested that chronic kinking may disrupt 
natural blood flow, leading to restenosis or reocclusions.12 In our study, 4 of the 
7 patients with restenosis exhibited kinking with leg flexion following treatment, 
supporting the assumption that kinking is associated with restenosis. Based on 
this observation, the “leave nothing behind” strategy could be considered the 
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optimum treatment approach, as performing only PTA helped restore the natural 
deformation behavior of the SFA and popliteal arteries. However, bailout 
stenting will continue to be utilized for arteries that are dissected or suboptimally 
dilated. Therefore, to decrease the possible restenosis rates caused by stent 
implantation, future stents would benefit from designs that enable axial 
shortening during leg flexion. Another, albeit more controversial, solution would 
be to place an additional stent into the arteries that experience kinking. This 
would help smooth the transition from the mechanical stiffness of the stented 
segment to the adjacent bare artery. The major risk with this approach concerns 
the formation of stenosis due to stenting a healthy artery, which may be inhibited 
to a certain extent by using drug-eluting stents.  
 Due to the limited number of studies and the differences in their designs, 
a direct comparison of our results with previous publications is difficult. In a 
previous preliminary study, 3D rotational angiography was used to measure the 
popliteal artery deformations in 5 patients with PAD.22 The average axial 
shortening and mean and maximum curvatures from that study compare 
favorably with our current pre-PTA measurements within the lesion. Nikanorov et 
al28 measured the axial elongation, bend radius, and deflection angle on 17 
patients who received the Absolute (Abbott Vascular) self-expanding stent. With 
a 70°/20° knee/hip flexion, the authors reported a mean axial compression of 
2.4%±0.4% in a combined segment of the SFA/proximal popliteal (2 patients) 
and a mean curvature of 0.1 cm -1 in the popliteal artery (6 patients). Finally, 
Ganguly et al29 reported a mean axial shortening of 4%±3% and a mean 
curvature change of 0.05 cm -1 in the stented femoral arteries (unknown stent 
types) of 13 patients with an unknown degree of leg flexion.  The results from 
both studies compare favorably with our observations. The differences can be 
attributed to the number of patients included in the study, to the different stent 
designs implanted in the patients, and to the different methods used to perform 
the measurements. 
 
Limitations 
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The main limitation of the present study concerns the reconstruction of the 3D 
models from only two 2D radiographic images. Due to the sparse number of 
views, the identification of corresponding side branches was not possible in 
most cases. Besides changes to the artery’s length and cu rvature, leg flexion 
also caused twisting of the SFA and popliteal arteries. However, the twist angle 
could not be measured as it required accurate positions of the side branches 
and their deviation from the main branch. Due to mismatched field of views 
between the angiographic images, the severity of the calcifications and, in some 
instances, the lengths of the lesions, it was not always possible to identify the 
proximal and distal regions, leading to varying reductions in the sample sizes of 
these subgroups. However, with the exception of 1 subgroup, the inclusion was 
above 80%, thereby providing a sufficient number of datasets to allow relevant 
statistical evaluations.  
 All the calculations were performed on 2 static positions, so the 
measurements actually represent the deformations at a single point that is found 
during the walking cycle rather than considering a dynamic walking situation, 
which includes the effect of muscle contraction on vessel shape. Finally, a 
follow-up study is needed to further support the hypothesis that kinking 
significantly increases the risk of restenosis.  
 
Conclusion 
The current study showed the different effects of the available endovascular 
treatment methods on FP segment deformations. In this context, PTA was 
observed to help in recovering the natural deformation behavior of the arteries. 
On the other hand, stent implantation limited the artery’s axial compressibility 
during leg flexion, which led to kinks when the stents were implanted in the 
sections of the FP segment that are normally subject to large deformations. 
Assuming kinking is associated with restenosis and reocclusion, our results 
would favor the “leave nothing behind” approach to FP revascularization. 
However, for arteries that require stent implantation, the current stent designs 
should be improved to allow for greater shortening with leg flexion. 
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Legends 
Figure 1. Angiographic images of the femoropopliteal (FP) segments from 3 
patients acquired prior to balloon angioplasty (A, C, E) and following primary 
stent implantation (B, D, F) during hip/knee flexion of 20°/70°. For all cases, the 
placement of the stents in the higher deformational sections of the FP segment 
increased the curvature compared to the pretreatment phase, leading to extreme 
deformations, such as kinking, with leg flexion.  
Figure 2. Angiographic images of the femoropopliteal (FP) segment acquired 
during hip/knee flexion of 20°/70° prior to (A) and following (B) balloon 
angioplasty. Dilation resolved the kinking observed in the pretreatment phase 
and returned the segment to a more natural deformation behavior.  
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Table 1. Patient Characteristics and Procedure Details. 
 
Age, y 69±10 
Men 20 
Fontaine stage IIb 
Calcification  
Moderate 23 
Severe 12 
Lesion length, mm 119±105 
Pre-PTA group 71±53 
Pre-stent group 168±120 
Total occlusions 18 
Region of the lesion  
CFA to mid/distal SFA 1 
Proximal to mid SFA 2 
Proximal to distal SFA 3 
Mid SFA 5 
Mid to distal SFA 11 
Distal SFA 6 
Distal SFA to popliteal artery 1 
Popliteal artery 6 
Patients treated with PTA 17 
Uncoated balloons 15 
Drug-coated balloons 2 
Patients treated with stents 18 
Pulsar-18 6 
EverFlex 9 
Zilver PTX 5 
Xpert 1 
Stent length, mm 168±131 
Abbreviations: CFA, common femoral artery; PTA, percutaneous transluminal 
angioplasty; SFA, superficial femoral artery.  
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Table 2. Axial Deformation and the Curvatures of the Femoropopliteal Segment During Hip/Knee Flexion Before 
and After Percutaneous Transluminal Angioplasty.  
 
 N Axial 
Deformatio
n, % 
Curvature, cm-1 
Mean Maximum 
Straight Flexed ∆ p Straight Flexed ∆ p 
Pre-PTA 17          
   Proximal to 
lesion 
14 –5.0±2.3 0.05±0.02 0.07±0.02 0.02±0.01 0.031 0.10±0.03 0.14±0.05 0.08±0.05 0.041 
   Lesion 17 –4.6±3.0 0.07±0.02 0.12±0.08 0.05±0.07 0.028 0.13±0.05 0.26±0.17 0.18±0.16 0.025 
   Distal to 
lesion 
14 –11.5±4.0 0.06±0.02 0.17±0.16 0.11±0.15 0.060 0.11±0.04 0.30±0.25 0.24±0.25 0.038 
Pre-stent 18          
   Proximal to 
lesion 
1 –8.0 0.06 0.17 0.11 — 0.11 0.34 0.28 — 
   Lesion 18 –6.4±3.4 0.05±0.02 0.09±0.04 0.04±0.03 0.004 0.12±0.04 0.19±0.08 0.12±0.04 0.008 
   Distal to 
lesion 
15 –12.9±3.6 0.06±0.02 0.16±0.05 0.10±0.06 0.005 0.13±0.05 0.33±0.12 0.28±0.14 0.004 
Post-PTA 17          
   Proximal to 
treated region 
14 –4.4±3.6 0.04±0.02 0.06±0.01 0.01±0.02 0.097 0.08±0.02 0.11±0.03 0.05±0.05 0.036 
   Lesion 17 –7.4±5.3 0.07±0.02 0.13±0.07 0.06±0.06 0.003 0.13±0.03 0.25±0.15 0.19±0.12 0.005 
   Distal to 
treated region 
15 –11.6±4.3 0.06±0.02 0.20±0.18 0.15±0.17 0.120 0.11±0.04 0.29±0.23 0.25±0.21 0.130 
Post-stent 18          
   Proximal to 
treated region 
14 –8.7±8.7 0.05±0.02 0.13±0.09 0.08±0.10 0.094 0.10±0.04 0.24±0.19 0.18±0.19 0.082 
   Lesion 18 –3.2±2.9 0.06±0.02 0.09±0.05 0.03±0.04 0.003 0.11±0.05 0.21±0.16 0.16±0.14 0.004 
   Distal to 
treated region 
15 –9.3±6.7 0.07±0.02 0.16±0.08 0.09±0.07 <0.00
1 
0.13±0.04 0.30±0.16 0.24±0.18 <0.001 
Abbreviation: PTA, percutaneous transluminal angioplasty.  
 
 
